[1] Thapar M, Russo MW, Bonkovsky HL. Statins and liver injury[J]. Gastroenterol Hepatol (NY), 2013, 9(9):605-606.[2] Yazigi NA. Long term outcomes after pediatric liver transplantation[J]. Pediatr Gastroenterol Hepatol Nutr,2013,16(4):207-218.[3] 张 媛,朱 英. 干细胞在肝损伤中的机制研究[J]. 中国医药科学,2015, 5(4):20-23.[4] Bandiera S, Pfeffer S, Baumert TF, et al. miR-122—a key factor and therapeutic target in liver disease[J]. J Hepatol,2015,62(2):448-457.[5] Wang Y, Wang J, Bai D, et al. Cell proliferation is promoted by compressive stress during early stage of chondrogenic differentiation of rat BMSCs[J]. J Cell Physiol,2013,228(9):1935-1942.[6] Gade NE, Pratheesh MD, Nath A, et al. Molecular and cellular characterization of buffalo bone marrow-derived mesenchymal stem cells[J]. Reprod Domest Anim,2013,48(3):358-367.[7] Hang HL, Xia Q. Role of BMSCs in liver regeneration and metastasis after hepatectomy[J]. World J Gastroenterol,2014,20(1):126-132.[8] Liu X, Wang Z, Wang R, et al. Direct comparison of the potency of human mesenchymal stem cells derived from amnion tissue, bone marrow and adipose tissue at inducing dermal fibroblast responses to cutaneous wounds[J]. Int J Mol Med,2013,31(2):407-415.[9] Chiba Y, Kuroda S, Osanai T, et al. Impact of ageing on biological features of bone marrow stromal cells (BMSC) in cell transplantation therapy for CNS disorders: functional enhancement by granulocyte-colony stimulating factor (G-CSF)[J]. Neuropathology,2012,32(2):139-148.[10] Kuroda S. Transplantation of autologous bone marrow stromal cells (BMSC) for CNS disorders —Strategy and tactics for clinical application[J]. J Stem Cells Regen Med,2010,6(3):167-170.[11] Roderburg C, Benz F, Vargas CD, et al. Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases[J]. Liver Int,2015,35(4):1172-1184.[12] Starckx S, Batheja A, Verheyen GR, et al. Evaluation of miR-122 and other biomarkers in distinct acute liver injury in rats[J]. Toxicol Pathol,2013,41(5):795-804.[13] Zeisel MB, Pfeffer S, Baumert TF. miR-122 acts as a tumor suppressor in hepatocarcinogenesis in vivo[J]. J Hepatol,2013,58(4):821-823.[14] Hu J, Xu Y, Hao J, et al. MiR-122 in hepatic function and liver diseases[J]. Protein Cell, 2012,3(5):364-371.[15] Wen J, Friedman JR. miR-122 regulates hepatic lipid metabolism and tumor suppression[J]. J Clin Invest,2012,122(8):2773-2776. |